Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (5509)	10/17/1998 7:50:00 AM
From: nord	Read Replies (2) of 6136

Apparently Robertson Stevens suggested that AGPH may miss their numbers Well if RS did in fact suggest AGPH will miss their numbers either they know something the public doesn't or perhaps they have interest in keeping the stock price down, My bet is that whoever the shorts are they have had the ability to control the stock but the runup from the lows has got to be making them nervous add imnr earnings and the potential for more deals coming for agph and they will have to cover. all imo nice to see them cave under the pressure of people wanting into the most successful startup biotech growth company in many years. the future justs keep looking brighter for the company and pwa norden

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next